ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	12 December 2020
Main ID:	NCT03017638
Date of registration:	10/01/2017
Prospective Registration:	Yes
Primary sponsor:	Rabin Medical Center
Public title:	Analgesic Efficacy of Quadaratus Lumborum Block (QLB) for Laparoscopic Colectomy Surgery: A Prospective Case Control Trial to Evaluate Clinical Outcomes
Scientific title:	Analgesic Efficacy of Quadaratus Lumborum Block (QLB) for Laparoscopic Colectomy Surgery: A Prospective Observational Case Control Trial to Evaluate Clinical Outcomes
Date of first enrolment:	February 27, 2017
Target sample size:	14
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT03017638
Study type:	Observational
Study design:
Phase:

Countries of recruitment
Israel

Contacts

Name:	Shia Fein, MD
Address:
Telephone:
Email:
Affiliation:	Rabin Medical Center

Key inclusion & exclusion criteria

Inclusion Criteria:

All primary laparoscopic colectomy patients are eligible for inclusion in the study.

Exclusion Criteria:

- Previous abdominal surgery

- Allergy to local anesthetics or to systemic opioids

- Contraindication to regional anesthesia technique, such as local infection or
coagulopathy, or patients receiving anticoagulation therapy with smaller
specifications than listed in professional guidelines.

- Contraindication to the Quadratus lumborum block such as defects or interferences in
the abdominal wall obstructing anatomical structure visibility.

- Requirements of more than 30 mg morphine equivalent daily prior to surgery

- ASA IV or greater

- Psychiatric or cognitive disorders

- Incarceration

- Renal insufficiency with Cr > 2.0

- Hepatic failure

- Pregnancy

- Age under 18 years

Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Block

Intervention(s)

Other: Questionaire

Primary Outcome(s)

Verbal analogue scale (VAS) [Time Frame: 24 Hours]

Verbal analogue scale (VAS) [Time Frame: 48 hours]

Secondary Outcome(s)

Quality of recovery score (questionaire) four weeks postoperatively [Time Frame: 4 weeks]

Minimal saturation during PACU stay [Time Frame: 24 hours]

Development of postoperative respiratory complications until patient discharge [Time Frame: 1 week]

Quality of recovery score (questionaire) 1 day postoperatively [Time Frame: 24 hours]

Quality of recovery score (questionaire) 48 postoperatively [Time Frame: 48 hours]

Total opioid consumption at four weeks postoperatively [Time Frame: 4 weeks]

Total opioid consumption on postoperative day 1. [Time Frame: 24 hours]

Length of hospital stay [Time Frame: 1 week]

Total opioid consumption in PACU [Time Frame: 24 hours]

Total opioid consumption postoperative day 2 [Time Frame: 48 hours]

Secondary ID(s)

0832-16

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.